2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial …
2007 Writing Committee Members, JL Anderson… - Circulation, 2013 - Am Heart Assoc
It is important that the medical profession play a significant role in critically evaluating the
use of diagnostic procedures and therapies as they are introduced and tested in the …
use of diagnostic procedures and therapies as they are introduced and tested in the …
Acute coronary syndromes: diagnosis and management, part I
A Kumar, CP Cannon - Mayo Clinic Proceedings, 2009 - Elsevier
The term acute coronary syndrome (ACS) refers to any group of clinical symptoms
compatible with acute myocardial ischemia and includes unstable angina (UA), non—ST …
compatible with acute myocardial ischemia and includes unstable angina (UA), non—ST …
2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American …
EA Amsterdam, NK Wenger, RG Brindis… - Journal of the American …, 2014 - jacc.org
The recommendations listed in this CPG are, whenever possible, evidence based. An
extensive evidence review was conducted through October 2012, and other selected …
extensive evidence review was conducted through October 2012, and other selected …
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the …
comprehensive review of the published evidence for management of a given condition
according to ESC Committee for Practice Guidelines (CPG) policy. A critical evaluation of …
according to ESC Committee for Practice Guidelines (CPG) policy. A critical evaluation of …
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction: a report of the American College of …
JL Anderson, CD Adams, EM Antman… - Journal of the American …, 2007 - jacc.org
The ACC/AHA Task Force on Practice Guidelines was formed to make recommendations
regarding the diagnosis and treatment of patients with known or suspected cardiovascular …
regarding the diagnosis and treatment of patients with known or suspected cardiovascular …
Biomarkers in heart failure
E Braunwald - New England Journal of Medicine, 2008 - Mass Medical Soc
Heart failure results not only from cardiac overload or injury but also from a complex
interplay among genetic, neurohormonal, inflammatory, and biochemical changes acting on …
interplay among genetic, neurohormonal, inflammatory, and biochemical changes acting on …
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
N Rifai, MA Gillette, SA Carr - Nature biotechnology, 2006 - nature.com
Better biomarkers are urgently needed to improve diagnosis, guide molecularly targeted
therapy and monitor activity and therapeutic response across a wide spectrum of disease …
therapy and monitor activity and therapeutic response across a wide spectrum of disease …
Biomarkers of cardiovascular disease: molecular basis and practical considerations
RS Vasan - Circulation, 2006 - Am Heart Assoc
echocardiogram) may be expected to facilitate the identification of patients with chest pain of
an ischemic etiology (angina). In a patient presenting to the emergency department with …
an ischemic etiology (angina). In a patient presenting to the emergency department with …
Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association
EA Amsterdam, JD Kirk, DA Bluemke, D Diercks… - Circulation, 2010 - Am Heart Assoc
The management of low-risk patients presenting to emergency departments is a common
and challenging clinical problem entailing 8 million emergency department visits annually …
and challenging clinical problem entailing 8 million emergency department visits annually …
Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation …
Z Hijazi, J Oldgren, U Andersson, SJ Connolly… - Circulation, 2012 - Am Heart Assoc
Background—Cardiac biomarkers are strong predictors of adverse outcomes in several
patient populations. We evaluated the prevalence of elevated troponin I and N-terminal pro …
patient populations. We evaluated the prevalence of elevated troponin I and N-terminal pro …